- Our LinkedIn Page
- Our Twitter Feed
- Our Facebook Page
- Newsletter Subscribe to our monthly e-newsletter. Current Issue
- Our Flickr Feed
- Our YouTube Feed
Authors
- Abigail Hirsch
- Alan Eisenberg
- BIOtechNOW Editor
- Bruce Dale
- Celia Economides
- David Thomas
- George Goodno
- George MacDougall
- Jason Corum
- Jeff Joseph
- Jim Greenwood
- Karen Batra
- Kelly Cappio
- Lila Feisee
- Matt Carr
- Nathan Schock
- Paul Winters
- Paulina Ibarra
- Robbi Lycett
- Roy Zwahlen
- Sarah Sneeringer
- Sondra Behan
- Stephanie Fischer
- Stephen Marmaras
- Timothy Coetzee
- Tracy Cooley
Tags
BIO ethanol global food crisis One-on-One's Partnering indirect land use change renewable fuel standard Climate Change biotechnology Plant biotechnology greenhouse gas emissions Benefits of biotech crops Animal biotechnology Food BIO Investor Forum Greenhouse Gas Emission Biofuel Technology Food and Fuel agricultureCorporate
- Biofuels & Climate Change
- Biotech Blog
- Business & Investments
- Business of Biotech
- Capital Business
- Corporate
- Environmental & Industrial
- Events
- Farmer Gene
- FierceBiotech
- Food & Agriculture
- Genome Alberta
- Health
- Inside BIO Industry Analysis
- IP Watchdog
- Life Science Leader
- One-on-One Partnering
- Patent Baristas
- Patent Docs
- Patently BIOtech
- PharmTech Talk
- Public Policy
- Snapshot
- Trade Secrets Blog
Latest From Biotech Now
Biotech Crops Are Winning Over Farmers
Fortune magazine’s Marc Gunther wrote a blog this week about the growing adoption of biotech crops and the debate over their use: The debate over biotech crops has become predictable. In his 2012 annual letter from the Gates Foundation, Bill Gates, who has a near-religious faith in technology and innovation, argues that an “extremely important revolution” in plant science, i.e., genetically-engineered crops, can help farmers in poor countries by giving them access to new varieties Read More >
A Very Big BTK January
We all heard reports that January was a great start to 2012 for the stock market, and even more so for Biotech. But how big was it, really? The Amex Biotech Index (the “BTK“) had its biggest January on record, since 1992, with a +21% pop: The companies behind the numbers? The Nasdaq Biotech Index was up 11%, the best in a decade. The January 2000 jump of 15% is still a tough month to beat Read More >
The BioGENEius Challenge: Prarthana Dalal
By Prarthana Dalal, 2011 International BioGENEius Challenge 1st Place Winner Project Title: Modeling of human non-deletional hereditary persistence of fetal hemoglobin (HPFH) conditions in β-globin locus transgenic mouse models: The -175 (T to C) and -195 (C to G) A-gamma globin gene point mutations Project Description: My project was focused on hemoglobingenetics and how sequence changes can effect fetal hemoglobin production in mouse models, which can be used to understand treatment mechanisms for sickle cell Read More >
The BioGENEius Challenge: Priyen Patel
By Priyen Patel, 2011 U.S. National BioGENEius Media Award Winner Project Title: Over-the-Counter and In Your Water? The Most Effective Filtration of Pharmaceuticals Project Description: Research shows minute concentrations of drugs in 51 million Americans’ water, leading to tumors and reproductive problems in fish and slowing the growth of kidney cells in humans. I focused on filtering ibuprofen and acetaminophen and my results are: the water distiller (100% effective), the activated carbon filter and ion Read More >
BIO CEO Company Snapshot: ImmunoGen, Inc.
In the latest Company Snapshot for the 2012 BIO CEO & Investor Conference in New York City, we’re profiling ImmunoGen, Inc. which will be presenting at the event. We spoke with ImmunoGen, Inc. CEO Daniel Junius and he outlined his organization’s priorities and challenges as well as how his company differentiates themselves from the competition. Company Snapshot What are the short-term and long-term priorities for your company? Our highest priority today is building and advancing our pipeline Read More >
